Ratings
0
Nobody has rated this yet. Be the first!
Works
3
Crizotinib in ROS1-rearranged non-small-cell lung cancer.
Resensitization to Crizotinib by the Lorlatinib ALK Resistance Mutation L1198F.
BRAF V600E mutations are common in pleomorphic xanthoastrocytoma: diagnostic and therapeutic implications
